INBX Cash & Equivalents
Inhibrx Biosciences Inc · Cash & Equivalents
INBX Cash & Equivalents
Latest reported$124.22Mperiod ending
INBX FY Cash & Equivalents ($20.03M → $124.22M)
Annual Cash & Equivalents
High-resolution chart · PNG
INBX cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 124,220,000 | |
| 152,596,000 | |
| 277,924,000 | |
| 273,865,000 | |
| 131,301,000 | |
| 128,664,000 | |
| 11,540,000 | |
| 2,103,000 | |
| 13,470,000 | |
| 20,025,000 |